FGF18 Alleviates Sepsis-Induced Acute Lung Injury by Inhibiting the NF-κB Pathway

A mouse model of acute lung injury and HUVEC stimulated with lipopolysaccharide was established in vivo and in vitro. AAV-FGF18 and fibroblast growth factor 18 (FGF18) proteins were used in C57BL/6J mice and HUVEC, respectively.